reports
Transactions in connection with share buyback programme
Transactions in connection with share buyback programme Company Announcement Copenhagen, 19 May 2025 No. 34/2025 Transactions in connection with share buyback programmeISS A/S, a leading workplace experience and facility management company, announced on 20 February 2025 a new share buyback programme, see company announcement no. 12/2025. The share buyback programme is executed in accordance Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 (the “Market Abuse Regulation”) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also r...
- Wedbush Research
- Alicia Reese
- Kade Barr
- Matthew McCartney
- Michael Pachter
- ABGSC IT Research
- Oscar Rönnkvist
- Simon Jönsson
Transactions in connection with share buyback programme
Transactions in connection with share buyback programme Company Announcement Copenhagen, 12 May 2025No. 33/2025 Transactions in connection with share buyback programmeISS A/S, a leading workplace experience and facility service company, announced on 20 February 2025 a new share buyback programme, see company announcement no. 12/2025. The share buyback programme is executed in accordance Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 (the “Market Abuse Regulation”) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also ref...
ISS A/S reduces treasury shares to less than 5% of share capital
ISS A/S reduces treasury shares to less than 5% of share capital Company Announcement Copenhagen, 12 May 2025 No. 32/2025 ISS A/S reduces treasury shares to less than 5% of share capital In accordance with Section 31 of the Capital Market Act, it is hereby announced that ISS A/S as of today owns a total of 3,087,915 treasury shares of nominally DKK 1, hence less than 5% of the total share capital and the total voting rights in the Company.The decrease in number of treasury shares is a consequence of the share capital reduction resolved by the Company’s Annual General Meeting on 11 April ...
Reduction of share capital
Reduction of share capital Company Announcement Copenhagen, 12 May 2025 No. 31/2025 Reduction of share capital ISS A/S (the “Company”), a leading workplace experience and facility management company, today announces that the capital decrease in connection with cancellation of own shares has been completed. Reference is made to the company announcement of 11 April 2025 regarding the annual general meeting’s approval of the decision to decrease the share capital with nominally DKK 11,468,226 from nominally DKK 185,668,226 to nominally DKK 174,200,000 by cancellation of own shares. Toda...
- ABGSC Seafood Research
- Martin Kaland
- Simon Brun
- ABGSC Seafood Research
- Martin Kaland
- Simon Brun
- ABGSC Strategy Research
- Christer Linde
- ABGSC Seafood Research
- Martin Kaland
- Simon Brun
- ABGSC IT Research
- Oscar Rönnkvist
- Simon Jönsson
- Nicolas David
- Thomas Zlowodzki
EVT EVOTEC SE
ISS ISS A/S
MTU MANITOU BF SA
ELG ELMOS SEMICONDUCTOR SE
BOSS HUGO BOSS AG
NOEJ NORMA GROUP SE
PNL POSTNL NV
G24 SCOUT24 AG
NANO NANOBIOTIX SA
ELIS ELIS SA
COFA COFACE SA
IDR INDRA SISTEMAS S.A. CLASS A
SAE SHOP APOTHEKE EUROPE NV
RUI RUBIS SCA
SANT S&T AG
TMV TEAMVIEWER AG
- Nicolas David
- Thomas Zlowodzki
EVT EVOTEC SE
ISS ISS A/S
MTU MANITOU BF SA
ELG ELMOS SEMICONDUCTOR SE
BOSS HUGO BOSS AG
NOEJ NORMA GROUP SE
PNL POSTNL NV
G24 SCOUT24 AG
NANO NANOBIOTIX SA
ELIS ELIS SA
COFA COFACE SA
IDR INDRA SISTEMAS S.A. CLASS A
SAE SHOP APOTHEKE EUROPE NV
RUI RUBIS SCA
SANT S&T AG
TMV TEAMVIEWER AG
- Fehmi Ben Naamane
- Johanna Jourdain
- Fehmi Ben Naamane
- Johanna Jourdain
Transactions in connection with share buyback programme
Transactions in connection with share buyback programme Company Announcement Copenhagen, 5 May 2025 No. 29/2025 Transactions in connection with share buyback programmeISS A/S, a leading workplace experience and facility service company, announced on 20 February 2025 a new share buyback programme, see company announcement no. 12/2025. The share buyback programme is executed in accordance Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 (the “Market Abuse Regulation”) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also refer...
- Alexander Aukner
LSG LEROY SEAFOOD GROUP ASA
AUSS AUSTEVOLL SEAFOOD ASA
AKVA AKVA GROUP ASA
SALM SALMAR ASA
GSF GRIEG SEAFOOD ASA
MOWI MOWI ASA
BAKKA BAKKAFROST P/F
SALMOCAM SALMONES CAMANCHACA SA
IFISH ICE FISH FARM AS
ASA ATLANTIC SAPPHIRE
SALME SALMON EVOLUTION HOLDING
KING THE KINGFISH COMPANY NV
AKBM AKER BIOMARINE
ISLAX ARNARLAX AS
AFISH ARCTIC FISH HOLDING AS
MAS MÅSØVAL
- Wedbush Research
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
WELL WELLTOWER INC.
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FB FACEBOOK INC. CLASS A
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
CDR CD PROJEKT S.A.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
VTR VENTAS INC.
ISR ISORAY
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
DELL DELL TECHNOLOGIES INC CLASS C
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
SMCI SUPER MICRO COMPUTER
IDYA INC.
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
KROS ADICET BIO INC
ITOS KEROS THERAPEUTICS
ZNTL ITEOS THERAPEUTICS
LRMR ZENTALIS PHARMACEUTICALS
PRAX LARIMAR THERAPEUTICS INC
U PRAXIS PRECISION MEDICINES
TVTX UNITY SOFTWARE
VRDN TRAVERE THERAPEUTICS INC
DAWN VIRIDIAN THERAPEUTICS INC
ELEV DAY ONE BIOPHARMACEUTICALS INC
MRVL ELEVATION ONCOLOGY
STX MARVELL TECHNOLOGY INC
APP SEAGATE TECHNOLOGY HLDGS PLC
ATXS APPLOVIN CORP
GFS ASTRIA THERAPEUTICS INC
GMTX GLOBALFOUNDRIES INC
VIGL GEMINI THERAPEUTICS INC
TYRA VIGIL NEUROSCIENCE INC
EWTX TYRA BIOSCIENCES INC
DDI EDGEWISE THERAPEUTICS INC
APGE DOUBLEDOWN INTERACTIVE CO LTD
SKLZ APOGEE THERAPEUTICS INC
EMBRAC B SKILLZ INC
MXL-US EMBRACER GROUP AB
MAXLINEAR
INC.
- Alexander Aukner
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.